Related Experiment Video
Updated: Jun 20, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Calculating the prevalence of atopy in children
Jesús Garde1, Daniel Hervás, Nuria Marco
1Department of Pediatric Allergy, Elche General University Hospital, Elche, Spain.
Insights
This study found that 20% of children referred for drug allergy were atopic, with prevalence increasing with age. Allergen sensitization was very high in older children with asthma and rhinoconjunctivitis.
Area of Science:
- Pediatric Allergy and Immunology
- Epidemiology
- Clinical Medicine
Background:
- Atopy is a significant risk factor for common allergic diseases in children, including asthma, rhinitis, atopic eczema, and urticaria.
- Previous studies on pediatric atopy prevalence show considerable variation, limiting reliable extrapolation of findings.
- This study aimed to determine atopy and related disease prevalence in a pediatric population using a novel methodology.
Purpose of the Study:
- To calculate the prevalence of atopy, defined by allergen sensitization, in a pediatric cohort.
- To assess the prevalence of atopy-related diseases such as asthma, rhinitis, urticaria, and atopic eczema.
- To analyze the characteristics and age-related trends of atopy and associated conditions.
Main Methods:
- A retrospective study was conducted on children initially referred for suspected drug allergy.
- The drug allergy diagnosis was ultimately discarded for the majority of the study participants.
- Prevalence of atopy (allergen sensitization) and specific allergic diseases were evaluated.
Main Results:
- Of 342 patients, 325 (95%) had their drug allergy diagnosis discarded. Overall atopy prevalence was 20% in the studied pediatric sample.
- Atopy prevalence and allergen sensitization increased significantly with age, from 42.3% in 0-3 year olds to 93.3% in 7-14 year olds (p < 0.0001).
- Prevalence of asthma was 11.5% (0-3 yrs) decreasing to 7% (7-14 yrs), while rhinoconjunctivitis prevalence reached 20% in the 7-14 year old group.
Conclusions:
- The employed methodology appears suitable for estimating atopy prevalence in pediatric populations.
- A very high prevalence of allergen sensitization was observed in children aged 7-14 years with co-existing asthma and/or rhinoconjunctivitis.
- Findings highlight the significant burden of atopy and related respiratory allergies in older children.
Background:
Atopy is an important risk factor for asthma, rhinitis, atopic eczema and urticaria. For this reason, several studies have been done to determine the prevalence of atopy in the paediatric population. The important differences among these studies do not allow the extrapolating of results. In this study, we calculate the prevalence of atopy and atopy-related diseases in a paediatric population using a different methodology.
Methods:
Retrospective study among children referred for drug allergy in which the latter was discarded. We evaluated the prevalence of atopy (measured by allergen sensitisation), asthma, rhinitis, urticaria, atopic eczema and their characteristics.
Results:
Three hundred and forty-two patients were studied for adverse drug reaction. This was discarded in 325/342 patients. 20 % of the children in the sample were atopic. Atopy prevalence increased with age. Some atopy related disease was observed in 83/325 (25.5 %) children. Among these children allergen sensitisation increased from 42.3 % in the 0-3 years age group to 93.3 % in the 7-14 age group (p < 0.0001). Prevalence of asthma was 11.5 %, 10.2 % and 7 % in the 0-3, 4-6 and 7-14 age groups, respectively. Prevalence of rhinoconjunctivitis increased through age groups with a prevalence of 20 % among the 7 to 14-year old children.
Conclusion:
The use of this type of methodology seems to be correct to estimate the prevalence of atopy. Prevalence of allergen sensitisation is very high among 7 to 14-year old children with asthma and/or rhinoconjunctivitis.
Related Concept Videos
Asthma I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Probability Laws
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations

